'$GILD on call: No knowledge of additional #coronavirus responses to remdesivir. Waiting for clinical data. On manufacturing capacity: "We are investing heavily to be prepared as best we can."' -Tweet From STAT's Adam Feuerstein
Benzinga Newsdesk